1. Home
  2. NTIP vs GDTC Comparison

NTIP vs GDTC Comparison

Compare NTIP & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTIP
  • GDTC
  • Stock Information
  • Founded
  • NTIP 1990
  • GDTC 2018
  • Country
  • NTIP United States
  • GDTC Singapore
  • Employees
  • NTIP N/A
  • GDTC N/A
  • Industry
  • NTIP Multi-Sector Companies
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTIP Miscellaneous
  • GDTC Health Care
  • Exchange
  • NTIP Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • NTIP 32.9M
  • GDTC 29.4M
  • IPO Year
  • NTIP 1998
  • GDTC 2023
  • Fundamental
  • Price
  • NTIP $1.40
  • GDTC $2.70
  • Analyst Decision
  • NTIP
  • GDTC Buy
  • Analyst Count
  • NTIP 0
  • GDTC 1
  • Target Price
  • NTIP N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • NTIP 12.3K
  • GDTC 29.3K
  • Earning Date
  • NTIP 03-07-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • NTIP 7.25%
  • GDTC N/A
  • EPS Growth
  • NTIP N/A
  • GDTC N/A
  • EPS
  • NTIP N/A
  • GDTC N/A
  • Revenue
  • NTIP $1,881,000.00
  • GDTC $330,254.00
  • Revenue This Year
  • NTIP N/A
  • GDTC $14.71
  • Revenue Next Year
  • NTIP N/A
  • GDTC N/A
  • P/E Ratio
  • NTIP N/A
  • GDTC N/A
  • Revenue Growth
  • NTIP 129.39
  • GDTC N/A
  • 52 Week Low
  • NTIP $1.22
  • GDTC $1.20
  • 52 Week High
  • NTIP $2.25
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • NTIP 56.89
  • GDTC 52.51
  • Support Level
  • NTIP $1.35
  • GDTC $2.55
  • Resistance Level
  • NTIP $1.41
  • GDTC $2.94
  • Average True Range (ATR)
  • NTIP 0.02
  • GDTC 0.22
  • MACD
  • NTIP 0.00
  • GDTC 0.02
  • Stochastic Oscillator
  • NTIP 100.00
  • GDTC 67.74

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: